CA2095729A1 - Peptides solubles du recepteur du mannose - Google Patents

Peptides solubles du recepteur du mannose

Info

Publication number
CA2095729A1
CA2095729A1 CA002095729A CA2095729A CA2095729A1 CA 2095729 A1 CA2095729 A1 CA 2095729A1 CA 002095729 A CA002095729 A CA 002095729A CA 2095729 A CA2095729 A CA 2095729A CA 2095729 A1 CA2095729 A1 CA 2095729A1
Authority
CA
Canada
Prior art keywords
peptide
mannose receptor
ser
nucleic acid
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002095729A
Other languages
English (en)
Inventor
Raymond A. B. Ezekowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2095729A1 publication Critical patent/CA2095729A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002095729A 1990-11-06 1991-11-06 Peptides solubles du recepteur du mannose Abandoned CA2095729A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60991590A 1990-11-06 1990-11-06
US609,915 1990-11-06
PCT/US1991/008320 WO1992007579A1 (fr) 1990-11-06 1991-11-06 Peptides solubles recepteurs de mannose

Publications (1)

Publication Number Publication Date
CA2095729A1 true CA2095729A1 (fr) 1992-05-07

Family

ID=24442877

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002095729A Abandoned CA2095729A1 (fr) 1990-11-06 1991-11-06 Peptides solubles du recepteur du mannose

Country Status (5)

Country Link
EP (1) EP0568539A4 (fr)
JP (1) JPH06501620A (fr)
AU (1) AU9040591A (fr)
CA (1) CA2095729A1 (fr)
WO (1) WO1992007579A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6623096A (en) 1995-07-27 1997-02-26 Imperial College Of Science, Technology And Medicine Methods of predicting the outcome of infection
AU8748198A (en) 1997-08-21 1999-03-16 Takara Shuzo Co., Ltd. Carcinostatic agents
KR100643818B1 (ko) 2000-05-08 2006-11-10 셀덱스 쎄라퓨틱스, 인크. 수상세포에 대한 인간 모노클로날 항체
US7560534B2 (en) 2000-05-08 2009-07-14 Celldex Research Corporation Molecular conjugates comprising human monoclonal antibodies to dendritic cells
US9259459B2 (en) 2003-01-31 2016-02-16 Celldex Therapeutics Inc. Antibody vaccine conjugates and uses therefor
EP1594533B1 (fr) 2003-01-31 2012-04-11 Celldex Research Corporation Conjugues vaccinaux a base d'anticorps et leurs applications
DK2224954T3 (en) 2007-11-07 2014-03-03 Celldex Therapeutics Inc Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
AU2009319336B2 (en) * 2008-11-27 2015-03-26 Bavarian Nordic A/S Promoters for recombinant viral expression
GB201717977D0 (en) * 2017-10-31 2017-12-13 Univ Court Of The Univ Of Aberdeen Treatment of anaemia
US20230365647A1 (en) 2020-06-30 2023-11-16 Zalvac Ab Mannose receptor-derived peptides for neutralizing pore-forming toxins for therapeutic uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001519A1 (fr) * 1987-08-20 1989-02-23 Children's Hospital Corporation Proteine humaine liant le mannose
CA1322972C (fr) * 1988-03-07 1993-10-12 Pall Corporation Systeme d'absorption sans chauffage pour la purification et le fonctionnement d'air

Also Published As

Publication number Publication date
WO1992007579A1 (fr) 1992-05-14
AU9040591A (en) 1992-05-26
EP0568539A4 (en) 1994-07-06
EP0568539A1 (fr) 1993-11-10
JPH06501620A (ja) 1994-02-24

Similar Documents

Publication Publication Date Title
EP1289564B1 (fr) Fusions et conjugues de recepteurs de lymphocytes t et procedes d'utilisation correspondants
US5270199A (en) Human mannose-binding protein
FI116943B (fi) Menetelmä kasvainkuoliotekijän reseptoria sisältävien fuusioproteiinien valmistamiseksi ja niitä koodaava DNA ja vektori
US5820866A (en) Product and process for T cell regulation
EP0991759A1 (fr) Membre ntn-2 de la famille des ligands du facteur de necrose tumorale (tnf)
CN100558745C (zh) 同种排斥反应的特异性抑制
EP1012292A1 (fr) Element ntn-2 de la famille des ligands du tnf
EA022932B1 (ru) Димерные слитые белки vstm3 и связанные с ними композиции и способы
JPH06502301A (ja) 安定タンパク質コアに結合されたタンパク質ポリリガンド
CA2276090A1 (fr) N-smases recombinees et acides nucleiques les codant
WO1999007738A2 (fr) Nouveau recepteur orphelin
CA2095729A1 (fr) Peptides solubles du recepteur du mannose
WO1994013312A1 (fr) Adressine vasculaire de muqueuses, adn codant ladite adressine et expression de ladite adressine
US7456263B2 (en) P53 binding T cell receptor molecules
CA1341530C (fr) Inhibiteur de l'angiogenine
EP1027436A1 (fr) Adn et polypeptides recepteurs des proteines de semaphorine a codage viral
JPH03284700A (ja) 機能性ポリペプチド
ES2315011T3 (es) Polipeptidos de semaforina.
US6187909B1 (en) Viral encoded semaphorin protein receptor polypeptides
JPH05503219A (ja) ヒトドーパミン作用性受容体活性を有するポリペプチド、これらのポリペプチドをコードする核酸、これらのポリペプチドに対して活性の物質をスクリーニングするためのかかるポリペプチドの使用
JP2001500019A (ja) 顆粒球走化性タンパク質２変異体
JP3621883B2 (ja) ウイルスがコードするセマフォリンタンパク質受容体ｄｎａおよびポリペプチド
AU748168B2 (en) Viral encoded semaphorin protein receptor DNA and polypeptides
CA2224625A1 (fr) Ligands de p-selectine et procedes et molecules associes___
US20030095968A1 (en) Viral encoded semaphorin protein receptor DNA and polypeptides

Legal Events

Date Code Title Description
FZDE Dead